Pentoxifylline in the treatment of radiation-induced fibrosis

Journal of Clinical Oncology

Volumn 22, Issue 11, 2004, Pages 2207-2213

  Okunieff, Paul ^a   Augustine, Elizabeth ^a   Hicks, Jeanne E ^a   Cornelison, Terri L ^a   Altemus, Rosemary M ^a   Naydich, Boris G ^a   Ding, Ivan ^a   Huser, Amy K ^a   Abraham, Edward H ^a   Smith, Judith J ^a   Coleman, Norman ^a   Gerber, Lynn H ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR 2; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; RADIOPROTECTIVE AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FIBROSIS; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; MUSCLE STRENGTH; PAIN; PERIPHERAL EDEMA; PRIORITY JOURNAL; RADIATION; TREATMENT OUTCOME; ADOLESCENT; ADULT; AGED; BLOOD; DRUG EFFECT; MIDDLE AGED; RADIATION INJURY; RADIOTHERAPY; SOFT TISSUE INJURY;

ADOLESCENT; ADULT; AGED; CYTOKINES; FIBROSIS; HUMANS; MIDDLE AGED; PENTOXIFYLLINE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; RANGE OF MOTION, ARTICULAR; SOFT TISSUE INJURIES; TREATMENT OUTCOME;

EID: 2942657616     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.09.101     Document Type: Article

References (37)

1. Hellman S: Principles of cancer management: Radiation therapy, in Devita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 3rd ed. Philadelphia, Lippincott-Raven, 1997, pp 307-332
2. Lefaix JL, Delanian S, Vozenin MC, et al: Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopheral: An experimental study. Int J Radiat Oncol Biol Phys 43:839-847, 1999
3. Hallahan DE, Haimovitz-Friedman A, Kufe DW, et al: The role of cytokines in radiation oncology, in DeVita VT, Hellman S, Rosenberg SA (eds): Important Advances in Oncology. Philadelphia, Lippincott, 1993, pp 71-80
4. Neta R, Okunieff P: Cytokine-induced radiation protection and sensitization. Semin Radiat Oncol 6:306-320, 1996
5. Schreier T, Degen E, Baschong W: Fibroblast migration and proliferation during in vitro wound healing. A quantitative comparison between various growth factors and a low molecular weight blood dialysate used in the clinic to normalize impaired wound healing. Res Exp Med (Berl) 193:195-205, 1993
6. Rodemann HP, Bamberg M: Cellular basis of radiation-induced fibrosis. Radiother Oncol 35:83-90, 1995
7. Martin M, Remy J, Daburon F: In vitro growth potential of fibroblasts isolated from pigs with radiation-induced fibrosis. Int J Radiat Biol 49:821-828, 1986
8. Bernstein EF, Harisiadis L, Salomon G, et al: Transforming growth factor-beta improves healing of radiation-impaired wounds. J Invest Dermatol 97:430-434, 1991
9. Massague J: The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641, 1990
10. Roberts AB, McCune BK, Sporn MB: TGF-β: regulation of extracellular matrix. Kidney Int 41:557-559, 1992
11. Anscher MS, Murase T, Prescott DM, et al: Changes in plasma TGF levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 30:671-676, 1994
12. Anscher MS, Kong F-M, Murase T, et al: Short communication: Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ. Br J Radiol 68:331-333, 1995
13. McBride WH: Cytokine cascades in late normal tissue radiation responses. Int J Radiat Oncol Biol Phys 33:233-234, 1995
14. Marques LJ, Zheng L, Poulakis N, et al: Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 159:508-511, 1999
15. Delanian S, Porcher R, Balla-Mekias S, et al: Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21:2545-2550, 2003
16. Norkin CC, White DJ: Measurement of joint motion: A guide to goniometry. Philadelphia, PA, F. A. Davis Company, 1995
17. Joint Motion: Method of Measuring and Recording. American Academy of Orthopedic Surgery, Chicago, IL, 1985
18. Kendall FP, McCreary EK: Muscles testing and function. Baltimore, MD, Williams and Wilkins, 1983
19. Gerber L, Lampert M, Wood C, et al: Comparison of pain, motion and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat 21:139-145, 1992
20. Huskisson EC: Measurement of Pain. Lancet 2:1127-1131, 1974
21. Dezube BJ, Sherman ML, Fridovich-Keil JL, et al: Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot study. Cancer Immunol Immunother 36:57-60, 1993
22. Berman B, Duncan MR: Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol 92:605-610, 1989
23. Dower SK: Interleukin-1, in: Aggarwal BB, Gutterman JU (eds): Human Cytokines: Handbook for Basic and Clinical Research. Boston, MA, Blackwell Scientific Publications, 1992, pp 46-80
24. Peterson TC: Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 17:486-493, 1993
25. Chen Y, Williams JP, Ding I, et al: Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12:26-33, 2002
26. Pan LH, Ohtani H, Yamauchi K, et al: Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: An immunohistochemical analysis. Pathol Int 46:91-99, 1996
27. Piguet PF, Vesin C, Grau GE, et al: Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5:57-61, 1993
28. Kolb M, Margetts PJ, Anthony DC, et al: Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107:1529-1536, 2001
29. Lilly CM, Sandhu JS, Ishizaka A, et al: Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 139: 1361-1368, 1989
30. Dion MW, Hussey DH, Osborne JW: The effect of pentoxifylline on early and late radiation injury following fractionated irradiation in C3H mice. Int J Radiat Oncol Biol Phys 17:101-107, 1989
31. Futran ND, Trotti A, Gwede C: Pentoxifylline in the treatment of radiation-related soft tissue injury: Preliminary observations. Laryngoscope 107:391-395, 1997
32. Dion MW, Hussey DH, Doornbos JF, et al: Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys 19:401-407, 1990
33. Bianco JA, Singer JW: Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients. Blood 80:2683-2684, 1992
34. Clift RA, Bianco JA, Appelbaum FR, et al: A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 82:2025-2030, 1993
35. Attal M, Huguet F, Rubie H, et al: Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: A prospective, randomized trial. Blood 82:732-736, 1993
36. Cornelison TL, Okunieff P, Naydich BG, et al: Trial of pentoxifylline in patients with functional disability caused by radiation-induced advanced regional fibrosis: Preliminary report. Proc AACR 37:610, 1996 (abstr 4185)
37. Cornelison TL, Naydich BG, Hicks JE, et al: Trial of pentoxifylline in patients with functional disability caused by radiation-induced advanced regional fibrosis. Gynecol Oncol 64:269, 1997 (abstr 30)